Bayer Notches Dual EYLEA 8mg Wins With China nAMD Approval and EU 6-Month Interval Extension
High-dose aflibercept secured a regulatory victory in China as 6-month dosing nears European approval Good news apparently comes in twos…
The Potential for Better and Faster Drying with Longer Treatment Intervals
Sponsored by Bayer Experts share how aflibercept 8 mg could reshape clinical practice During the 16th Annual Congress on Controversies…
latest posts
![[Topcon] Presentation _1 Prof. Giannaccare thumbnail Shedding Light on Dry AMD with eye light® LM® LLLT (1) (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/01/Topcon-Presentation-_1-Prof.-Giannaccare-thumbnail-Shedding-Light-on-Dry-AMD-with-eye-light®-LM®-LLLT-1-1-579x326.png)
